X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (449) 449
Publication (52) 52
Patent (27) 27
Book Chapter (10) 10
Conference Proceeding (3) 3
Book Review (2) 2
Reference (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (210) 210
index medicus (163) 163
hematology (135) 135
oncology (113) 113
male (95) 95
female (91) 91
aged (85) 85
middle aged (84) 84
rituximab (81) 81
antineoplastic combined chemotherapy protocols - therapeutic use (73) 73
adult (62) 62
mantle cell lymphoma (59) 59
treatment outcome (58) 58
lymphomas (55) 55
non-hodgkins-lymphoma (54) 54
prognosis (50) 50
lymphoma, mantle-cell - drug therapy (48) 48
aged, 80 and over (46) 46
chemotherapy (41) 41
lymphoma, mantle-cell - pathology (37) 37
lymphoma, mantle-cell - therapy (37) 37
chronic lymphocytic-leukemia (36) 36
progression-free survival (34) 34
survival (34) 34
survival analysis (34) 34
cancer (33) 33
antineoplastic agents - therapeutic use (32) 32
follicular lymphoma (32) 32
lymphoma, mantle-cell - mortality (32) 32
transplantation (32) 32
chemistry (29) 29
neoplasm staging (28) 28
peptides (28) 28
human necessities (27) 27
hygiene (27) 27
lymphoma (27) 27
lymphoma, mantle-cell - genetics (27) 27
medical or veterinary science (27) 27
metallurgy (27) 27
organic chemistry (27) 27
preparations for medical, dental, or toilet purposes (27) 27
therapy (27) 27
cyclophosphamide (26) 26
recurrence (26) 26
abridged index medicus (25) 25
combined modality therapy (25) 25
lymphoma, follicular - drug therapy (25) 25
antibodies, monoclonal - therapeutic use (24) 24
immunochemotherapy (24) 24
disease-free survival (23) 23
expression (23) 23
lymphoma, mantle-cell - diagnosis (23) 23
b-cell lymphoma (22) 22
antineoplastic combined chemotherapy protocols - adverse effects (21) 21
clinical trials (21) 21
hemic and lymphatic diseases (21) 21
medicine & public health (21) 21
prospective randomized-trial (21) 21
care and treatment (20) 20
cyclophosphamide - administration & dosage (20) 20
drug therapy (20) 20
immunotherapy (20) 20
high-dose therapy (19) 19
radioimmunotherapy (19) 19
remission induction (19) 19
antibodies, monoclonal, murine-derived (18) 18
clinical trials as topic (18) 18
phase-ii (18) 18
research (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (18) 18
transplantation, autologous (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
hematopoietic stem cell transplantation (17) 17
lymphoma, follicular - mortality (17) 17
risk factors (17) 17
1st-line treatment (16) 16
antibodies, monoclonal, murine-derived - administration & dosage (16) 16
bortezomib (16) 16
cell line, tumor (15) 15
follow-up studies (15) 15
hematology, oncology and palliative medicine (15) 15
indolent lymphoma (15) 15
lymphoma, follicular - pathology (15) 15
minimal residual disease (15) 15
survival rate (15) 15
trial (15) 15
vincristine (15) 15
analysis (14) 14
doxorubicin (14) 14
drug administration schedule (14) 14
leukemia (14) 14
mutation (14) 14
randomized controlled trials as topic (14) 14
vincristine - administration & dosage (14) 14
anti-cd20 monoclonal-antibody (13) 13
antineoplastic agents - adverse effects (13) 13
doxorubicin - administration & dosage (13) 13
lymphocytes b (13) 13
medicine, general & internal (13) 13
open-label (13) 13
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (474) 474
German (16) 16
French (7) 7
Chinese (5) 5
Spanish (2) 2
Arabic (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2009, Volume 4, Issue 9, p. e6986
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1111 - 1122
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 11, pp. 1008 - 1018
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 6, pp. 507 - 516
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2015, Volume 12, Issue 7, pp. 376 - 378
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2005, Volume 23, Issue 9, pp. 1984 - 1992
Journal Article
Blood, ISSN 0006-4971, 10/2016, Volume 128, Issue 14, pp. 1782 - 1783
In this issue of Blood, Albertsson-Lindblad et al report on the efficacy of a bendamustine (B)/lenalidomide (LEN)/rituximab (R) combination in first-line... 
BENDAMUSTINE | TRIAL | 1ST-LINE TREATMENT | MANTLE-CELL LYMPHOMA | PHASE | PLUS RITUXIMAB | LENALIDOMIDE | OPEN-LABEL | HEMATOLOGY | INDOLENT | Lymphoma, Mantle-Cell | Humans | Combined Modality Therapy
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2085 - 2093
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2015, Volume 12, Issue 7, pp. 376 - 378
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10020, pp. 770 - 778
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article